2020 NAEPP Guidelines Update and GINA 2021—Asthma Care Differences, Overlap, and Challenges

Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial

(2020) Laurie A Lee et al.   Lancet Respiratory Medicine

2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group

(2020) Michelle M. Cloutier et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Tiotropium is efficacious in 6–17-year-olds with asthma, independent of T2 phenotype

(2019) Stanley J. Szefler et al.   Journal of Allergy and Clinical Immunology-In Practice

Controlled Trial of Budesonide–Formoterol as Needed for Mild Asthma

(2019) Richard Beasley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial

(2019) Jo Hardy et al.   LANCET

The Efficacy of add-on Sublingual Immunotherapy for Adult Asthma patients: A Meta-analysis and Systematic Review

(2018) Kan Xu et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Budesonide/formoterol maintenance and reliever therapy in adolescent patients with asthma

(2018) Carin Jorup et al.   EUROPEAN RESPIRATORY JOURNAL

Association of Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists With Asthma Control in Patients With Uncontrolled, Persistent Asthma

(2018) Diana M. Sobieraj et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Inhaled Combined Budesonide–Formoterol as Needed in Mild Asthma

(2018) Paul M. O’Byrne et al.   NEW ENGLAND JOURNAL OF MEDICINE

As-Needed Budesonide–Formoterol versus Maintenance Budesonide in Mild Asthma

(2018) Eric D. Bateman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Quadrupling Inhaled Glucocorticoid Dose to Abort Asthma Exacerbations

(2018) Tricia McKeever et al.   NEW ENGLAND JOURNAL OF MEDICINE

Allergen-Specific Immunotherapy in the Treatment of Pediatric Asthma: A Systematic Review

(2018) Jessica L. Rice et al.   PEDIATRICS

Effect of an Integrated Pest Management Intervention on Asthma Symptoms Among Mouse-Sensitized Children and Adolescents With Asthma

(2017) Elizabeth C. Matsui et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma

(2016) J. Christian Virchow et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

House dust mite sublingual immunotherapy is safe in patients with mild-to-moderate, persistent asthma: a clinical trial

(2015) P. Devillier et al.   ALLERGY

SQ house dust mite sublingually administered immunotherapy tablet (ALK) improves allergic rhinitis in patients with house dust mite allergic asthma and rhinitis symptoms

(2015) Holger Mosbech et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Assessment of Montelukast, Doxofylline, and Tiotropium With Budesonide for the Treatment of Asthma: Which Is the Best Among the Second-line Treatment? A Randomized Trial

(2015) Muhasaparur Ganesan Rajanandh et al.   CLINICAL THERAPEUTICS

Anticholinergic vs Long-Acting β-Agonist in Combination With Inhaled Corticosteroids in Black Adults With Asthma

(2015) Michael E. Wechsler et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The effect of fluticasone furoate/umeclidinium in adult patients with asthma: A randomized, dose-ranging study

(2015) Laurie A. Lee et al.   RESPIRATORY MEDICINE

Tiotropium or salmeterol as add-on therapy to inhaled corticosteroids for patients with moderate symptomatic asthma: two replicate, double-blind, placebo-controlled, parallel-group, active-comparator, randomised trials

(2015) Huib A M Kerstjens et al.   Lancet Respiratory Medicine

House dust mite sublingual immunotherapy is safe and appears to be effective in moderate, persistent asthma

(2014) L. Wang et al.   ALLERGY

Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: A randomized, double-blind, placebo-controlled trial

(2014) Holger Mosbech et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

SQ HDM SLIT-tablet (ALK) in treatment of asthma – Post hoc results from a randomised trial

(2014) F. de Blay et al.   RESPIRATORY MEDICINE

Efficacy analysis of three-year subcutaneous SQ-standardized specific immunotherapy in house dust mite-allergic children with asthma

(2014) YU HUI et al.   Experimental and Therapeutic Medicine

Sublingual Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and Asthma

(2013) Sandra Y. Lin et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Bronchial thermoplasty: Long-term safety and effectiveness in patients with severe persistent asthma

(2013) Michael E. Wechsler et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Combination of budesonide/formoterol on demand improves asthma control by reducing exercise-induced bronchoconstriction

(2013) Nikolaos Lazarinis et al.   THORAX

Beclometasone–formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial

(2013) Alberto Papi et al.   Lancet Respiratory Medicine

The contribution of sublingual immunotherapy to the achievement of control in birch-related mild persistent asthma: A real-life randomised trial

(2012) M. Marogna et al.   ALLERGOLOGIA ET IMMUNOPATHOLOGIA

Environmental assessment and exposure reduction of rodents: a practice parameter

(2012) Wanda Phipatanakul et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Comparison of Physician-, Biomarker-, and Symptom-Based Strategies for Adjustment of Inhaled Corticosteroid Therapy in Adults With Asthma

(2012) William J. Calhoun   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effectiveness of Home-Based, Multi-Trigger, Multicomponent Interventions with an Environmental Focus for Reducing Asthma Morbidity

(2011) Deidre D. Crocker et al.   AMERICAN JOURNAL OF PREVENTIVE MEDICINE

An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (FeNO) for Clinical Applications

(2011) Raed A. Dweik et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Effect of One-Year Subcutaneous and Sublingual Immunotherapy on Clinical and Laboratory Parameters in Children with Rhinitis and Asthma: A Randomized, Placebo-Controlled, Double-Blind, Double-Dummy Study

(2011) Ayfer Yukselen et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Efficacy and safety of immunotherapy for allergies to Alternaria alternata in children

(2011) Piotr Kuna et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma

(2011) Eric D. Bateman et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial

(2011) Fernando D Martinez et al.   LANCET

Daily or Intermittent Budesonide in Preschool Children with Recurrent Wheezing

(2011) Robert S. Zeiger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-term (5 year) safety of bronchial thermoplasty: Asthma Intervention Research (AIR) trial

(2011) Neil C Thomson et al.   BMC Pulmonary Medicine

Depigmented and Polymerised House Dust Mite Allergoid: Allergen Content, Induction of IgG4 and Clinical Response

(2010) M.T. Gallego et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Tiotropium Bromide Step-Up Therapy for Adults with Uncontrolled Asthma

(2010) Stephen P. Peters et al.   NEW ENGLAND JOURNAL OF MEDICINE

Quadrupling the Dose of Inhaled Corticosteroid to Prevent Asthma Exacerbations

(2009) Janet Oborne et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Preemptive Use of High-Dose Fluticasone for Virus-Induced Wheezing in Young Children

(2009) Francine M. Ducharme et al.   NEW ENGLAND JOURNAL OF MEDICINE

Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing

(2008) Leonard B. Bacharier et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial

(2008) Stanley J Szefler et al.   LANCET